Hypersensitivity Pneumonitis: Challenges of a Complex Disease.

Authors:
Calaras D; David A; Vasarmidi E; Antoniou K; Corlateanu A.

Journal:
Can Respir J

Publication Year: 2024

DOI:
10.1155/2024/4919951

PMCID:
PMC10810695

PMID:
38283656

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Can Respir J

Abbreviation: Can Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell Lung Cancer Cells by Inhibiting MCL-1 Exp…
Wang L; Xu L; Han S and 1 more (2024) - Transparency Score: 2/6
Clustered Cystic Changes in Long-Term Follow-Up Thin-Section Computed Tomographic Findings in Fibro…
Akira M; Suganuma N. (2024) - Transparency Score: 2/6
A Novel Scale to Assess Humidification during Noninvasive Ventilation: A Prospective Observational …
Pan L; Hong Y; Zhong X and 6 more (2023) - Transparency Score: 2/6
Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbat…
Komura M; Sato T; Suzuki Y and 10 more (2023) - Transparency Score: 2/6
Construction and Validation of a Predictive Model for the Risk of Ventilator-Associated Pneumonia i…
Li S; Shang L; Yuan L and 5 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest Authors Diana Calaras, Aliona David, Eirini Vasarmidi, and Alexandru Corlateanu declare no conflicts of interest related to the submitted work. Author Katerina Antoniou declares honoraria from Boehringer Ingelheim, Hoffmann La Roche, Chiesi, Astra-Zeneca, and GSK and research grants from Boehringer Ingelheim and Hoffmann La Roche."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025